v3.26.1
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Share Capital
Contributed Surplus
Accumulated Other Comprehensive Income (Loss)
Deficit
Total
Balance at beginning at Dec. 31, 2024 $ 291,169,769 $ 36,923,555 $ 1,413,118 $ (273,164,150) $ 56,342,292
Balance at beginning (in shares) at Dec. 31, 2024 199,693,442        
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY          
Share issuance $ 3,932,994       3,932,994
Share issuance (in shares) 8,192,031        
Share issuance costs $ (121,904)       (121,904)
Stock-based compensation-option   172,547     172,547
Stock-based compensation-DSU   337,434     337,434
Exchange difference on translating foreign operations     216,352   216,352
Net loss       (2,594,154) (2,594,154)
Balance at end at Jun. 30, 2025 $ 294,980,859 37,433,536 1,629,470 (275,758,304) 58,285,561
Balance at end (in shares) at Jun. 30, 2025 207,885,473        
Balance at beginning at Mar. 31, 2025 $ 294,983,309 36,987,136 1,431,405 (273,833,218) 59,568,632
Balance at beginning (in shares) at Mar. 31, 2025 207,885,473        
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY          
Share issuance costs $ (2,450)       (2,450)
Stock-based compensation-option   108,966     108,966
Stock-based compensation-DSU   337,434     337,434
Exchange difference on translating foreign operations     198,065   198,065
Net loss       (1,925,086) (1,925,086)
Balance at end at Jun. 30, 2025 $ 294,980,859 37,433,536 1,629,470 (275,758,304) 58,285,561
Balance at end (in shares) at Jun. 30, 2025 207,885,473        
Balance at beginning at Dec. 31, 2025 $ 294,980,859 37,621,329 1,598,066 (277,802,483) $ 56,397,771
Balance at beginning (in shares) at Dec. 31, 2025 207,885,473       207,885,473
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY          
Share issuance $ 118,086,240       $ 118,086,240
Share issuance (in shares) 53,192,000        
Share issuance costs $ (4,126,100)       (4,126,100)
Exercise of options $ 267,795       267,795
Exercise of options (in shares) 560,000        
Reallocation of contributed surplus $ 128,189 (128,189)      
Stock-based compensation-option   199,621     199,621
Stock-based compensation-DSU   666,321     666,321
Exchange difference on translating foreign operations     (4,873,364)   (4,873,364)
Net loss       (1,109,611) (1,109,611)
Balance at end at Jun. 30, 2026 $ 409,336,983 38,359,082 (3,275,298) (278,912,094) $ 165,508,673
Balance at end (in shares) at Jun. 30, 2026 261,637,473       261,637,473
Balance at beginning at Mar. 31, 2026 $ 409,336,983 37,626,458 (1,099,390) (275,528,340) $ 170,335,711
Balance at beginning (in shares) at Mar. 31, 2026 261,637,473        
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY          
Stock-based compensation-option   176,284     176,284
Stock-based compensation-DSU   556,340     556,340
Exchange difference on translating foreign operations     (2,175,908)   (2,175,908)
Net loss       (3,383,754) (3,383,754)
Balance at end at Jun. 30, 2026 $ 409,336,983 $ 38,359,082 $ (3,275,298) $ (278,912,094) $ 165,508,673
Balance at end (in shares) at Jun. 30, 2026 261,637,473       261,637,473